First Embryonic Stem-Cell Trial Gets Approval From the FDA

This is really big news. California-based Geron Corp has received a green light from the FDA to study stem-cell treatment for spinal cord injuries in up to 10 patients.

From the WSJ:

“This is the dawn of a new era in medical therapeutics,” said Thomas B. Okarma, Geron’s president and chief executive officer. The hope that stem-cell therapy will repair and regenerate diseased organs and tissue “goes beyond what pills and scalpels can ever do.”